Filing Flows

Filing Flows › Mimedx Group (MDXG) › Next earnings date

Mimedx Group (MDXG) earnings

Mimedx Group (MDXG) last reported on Oct 28, 2026: revenue $62.3M for the third quarter 2026. The next date is not set yet. It beat the EPS estimate in 50% of the quarters on record.

Beat rate50%

The last report

Mimedx Group reported revenue of $62.3M for the third quarter 2026 (-45% Y/Y), net loss $8.7M: Surgical $40.0M, Wound $22.3M. How it makes money → · Every quarter →

Mimedx Group: EPS against the estimate, last 5 reportsMimedx Group: EPS against the estimate, last 5 reportsEstimateReported$0.07$0.15Oct 25$0.11$0.14Feb 26−$0.04−$0.05Apr 26−$0.03−$0.05Jul 26$0.00−$0.01Oct 26
Latest (Oct 26): Estimate $0.00, Reported −$0.01.
MDXG: the stock's move on each reportMDXG: the stock's move on each reportJul 29, 2026-2.1%Apr 29, 2026-1.2%Feb 25, 2026-7.7%Oct 29, 2025+7.6%

Mimedx Group's latest quarter

Mimedx Group, Q3 2026: revenue $62.3M (-45% year over year), operating margin -18.8%, net loss $8.7M, operating cash flow $3.9M. The chart follows the revenue to costs, profit and cash.

Questions

When does MDXG report earnings?

The next date is not set yet.

Does Mimedx Group usually beat earnings?

It beat the consensus EPS estimate in 50% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.